AdaptHealth Corp. (AHCO)
AdaptHealth Statistics
Share Statistics
AdaptHealth has 134.87M shares outstanding. The number of shares has increased by -1.35% in one year.
Shares Outstanding | 134.87M |
Shares Change (YoY) | -1.35% |
Shares Change (QoQ) | 0.06% |
Owned by Institutions (%) | 97.57% |
Shares Floating | 86.6M |
Failed to Deliver (FTD) Shares | 14 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 9.92M, so 7.37% of the outstanding shares have been sold short.
Short Interest | 9.92M |
Short % of Shares Out | 7.37% |
Short % of Float | 11.4% |
Short Ratio (days to cover) | 6.01 |
Valuation Ratios
The PE ratio is 14.08 and the forward PE ratio is 10.35. AdaptHealth's PEG ratio is -0.12.
PE Ratio | 14.08 |
Forward PE | 10.35 |
PS Ratio | 0.39 |
Forward PS | 0.2 |
PB Ratio | 0.81 |
P/FCF Ratio | 5.4 |
PEG Ratio | -0.12 |
Enterprise Valuation
AdaptHealth Corp. has an Enterprise Value (EV) of 3.2B.
EV / Earnings | 35.34 |
EV / Sales | 0.98 |
EV / EBITDA | 10.53 |
EV / EBIT | 12.12 |
EV / FCF | 13.55 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.11.
Current Ratio | 1.33 |
Quick Ratio | 1.09 |
Debt / Equity | 0.11 |
Total Debt / Capitalization | 9.53 |
Cash Flow / Debt | 3.28 |
Interest Coverage | 2.08 |
Financial Efficiency
Return on equity (ROE) is 0.06% and return on capital (ROIC) is 10.54%.
Return on Equity (ROE) | 0.06% |
Return on Assets (ROA) | 0.02% |
Return on Capital (ROIC) | 10.54% |
Revenue Per Employee | $310,569.05 |
Profits Per Employee | $8,611.62 |
Employee Count | 10,500 |
Asset Turnover | 0.73 |
Inventory Turnover | 18.45 |
Taxes
Income Tax | 41.24M |
Effective Tax Rate | 0.3 |
Stock Price Statistics
The stock price has increased by -7.65% in the last 52 weeks. The beta is 1.3, so AdaptHealth's price volatility has been higher than the market average.
Beta | 1.3 |
52-Week Price Change | -7.65% |
50-Day Moving Average | 10.05 |
200-Day Moving Average | 10.3 |
Relative Strength Index (RSI) | 59.34 |
Average Volume (20 Days) | 1.5M |
Income Statement
In the last 12 months, AdaptHealth had revenue of 3.26B and earned 90.42M in profits. Earnings per share was 0.68.
Revenue | 3.26B |
Gross Profit | 681.09M |
Operating Income | 263.73M |
Net Income | 90.42M |
EBITDA | 303.37M |
EBIT | 263.73M |
Earnings Per Share (EPS) | 0.68 |
Balance Sheet
The company has 109.75M in cash and 165.41M in debt, giving a net cash position of -55.67M.
Cash & Cash Equivalents | 109.75M |
Total Debt | 165.41M |
Net Cash | -55.67M |
Retained Earnings | -562.18M |
Total Assets | 4.49B |
Working Capital | 188.8M |
Cash Flow
In the last 12 months, operating cash flow was 541.84M and capital expenditures -306.06M, giving a free cash flow of 235.78M.
Operating Cash Flow | 541.84M |
Capital Expenditures | -306.06M |
Free Cash Flow | 235.78M |
FCF Per Share | 1.76 |
Margins
Gross margin is 20.89%, with operating and profit margins of 8.09% and 2.77%.
Gross Margin | 20.89% |
Operating Margin | 8.09% |
Pretax Margin | 4.17% |
Profit Margin | 2.77% |
EBITDA Margin | 9.3% |
EBIT Margin | 8.09% |
FCF Margin | 7.23% |
Dividends & Yields
AHCO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 6.4% |
FCF Yield | 16.45% |
Analyst Forecast
The average price target for AHCO is $14, which is 31.7% higher than the current price. The consensus rating is "Buy".
Price Target | $14 |
Price Target Difference | 31.7% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | 1.26 |
Piotroski F-Score | 8 |